Increased Tau Phosphorylation and Aggregation in the Hippocampus of Mice Overexpressing Corticotropin-Releasing Factor

Autor: Shannon N. Campbell, Cheng Zhang, Eliezer Masliah, Louise Monte, Yvette Taché, Allyson D. Roe, Robert A. Rissman, Kenner C. Rice
Rok vydání: 2014
Předmět:
Aging
Pathology
Corticotropin-Releasing Hormone
hippocampus
Hippocampus
Neurodegenerative
Hippocampal formation
Alzheimer's Disease
Transgenic
Mice
stress
Corticotropin-releasing hormone
Receptors
2.1 Biological and endogenous factors
Chronic stress
Phosphorylation
Aetiology
Cognitive decline
Kinase
tau phosphorylation
General Neuroscience
corticotropin-releasing factor
General Medicine
Psychiatry and Mental health
Clinical Psychology
immunohistochemistry
Neurological
Cognitive Sciences
medicine.medical_specialty
Clinical Sciences
tau Proteins
Pathological
Internal medicine
Acquired Cognitive Impairment
medicine
Animals
Kinase activity
western blot
Neurology & Neurosurgery
electron microscopy
business.industry
Neurosciences
Alzheimer's Disease including Alzheimer's Disease Related Dementias (AD/ADRD)
Protein Aggregation
Brain Disorders
corticotropin-releasing factor receptor
Endocrinology
Dementia
Geriatrics and Gerontology
business
Zdroj: Journal of Alzheimer's disease : JAD, vol 43, iss 3
ISSN: 1875-8908
1387-2877
Popis: Clinical and basic science research suggests that stress and/or changes in central stress signaling intermediates may be involved in Alzheimer's disease (AD) pathogenesis. Although the links between stress and AD remain unsettled, data from our group and others have established that stress exposure in rodents may confer susceptibility to AD pathology by inducing hippocampal tau phosphorylation (tau-P). Work in our laboratory has shown that stress-induced tau-P requires activation of the type-1 corticotropin-releasing factor receptor (CRFR1). CRF overexpressing (CRF-OE) mice are a model of chronic stress that display cognitive impairment at 9-10 month of age. In this study we used 6-7 month old CRF-OE mice to examine whether sustained exposure to CRF and stress steroids would impact hippocampal tau-P and kinase activity in the presence or absence of the CRFR1-specific antagonist, R121919, given daily for 30 days. CRF-OE mice had significantly elevated tau-P compared to wild type (WT) mice at the AT8 (S202/T204), PHF-1 (S396/404), S262, and S422 sites. Treating CRF-OE mice with R121919 blocked phosphorylation at the AT8 (S202/T204) and PHF-1 (S396/404) sites, but not at the S262 and S422 sites and reduced phosphorylation of c-Jun N Terminal Kinase (JNK). Examination of hippocampal extracts from CRF-OE mice at the ultrastructural level revealed negatively stained round/globular aggregates that were positively labeled by PHF-1. These data suggest critical roles for CRF and CRFR1 in tau-P and aggregation and may have implications for the development of AD cognitive decline.
Databáze: OpenAIRE